Refine by
Implant Technology Articles & Analysis
70 news found
In a ground-breaking advancement for cardiovascular care, Hiden Analytical Ltd is proud to announce a surface measurement technique for devices critical in the treatment of heart disease. Utilizing the most sensitive surface analysis technology, Secondary Ion Mass Spectrometry (SIMS), Hiden Analytical is setting new standards in the safety, efficacy, and innovation of stent technology. Surgical ...
When the number of elderly people occupies a large proportion of the total population of society, concern for the life and health of the elderly is a topic for the whole society. With the development of technology, modern medicine plays an important role in the diagnosis and treatment of common diseases in the elderly. In order to maintain the quality of life into old age, at the ...
Under the development and distribution agreement, THINK and Curexo will work together to include certain existing THINK technology and certain newly developed technology in Curexo’s CUVIS-Joint orthopedic surgical robot platform. ...
Unlike other cardiac monitoring technologies, measurements only take 20 seconds and don’t require a wearable device or surgical implant, allowing the technology to seamlessly integrate into a patient’s daily life. ...
Mehendale served in leadership roles at Stryker, Zimmer-Biomet, and United Technologies. “We are excited that Park has joined our leadership ...
To see video, please click here About the Stentrode Synchron’s flagship technology, the Stentrode, is an endovascular brain implant designed to enable patients to wirelessly control digital devices through thought and improve functional independence. Synchron’s foundational technology, a motor neuroprosthesis (MNP), or motor BCI, is ...
Based on his nearly two decades of experience in selling enabling technologies such as navigation and surgical robots, Mr. Fronk has great instincts regarding customer expectations, commercial models and user experiences with enabling technologies. ...
About the Stentrode Synchron’s flagship technology, the Stentrode, is an endovascular brain implant designed to enable patients to wirelessly control digital devices through thought and improve functional independence. Synchron’s foundational technology, a motor neuroprosthesis (MNP), or motor BCI, is implanted via ...
This ‘community-first’ architecture will result in a successful user interface to serve not only the ALS population, but everyone who can benefit from emerging technologies like the Stentrode.” Synchron’s flagship technology, the Stentrode, is an endovascular brain implant designed to enable patients to wirelessly control ...
About the Stentrode Synchron’s flagship technology, the Stentrode, is an endovascular brain implant designed to enable patients to wirelessly control digital devices through thought and improve functional independence. Synchron’s foundational technology, a motor neuroprosthesis (MNP), is implanted via the jugular ...
MEDTEQ+ is the pan-Canadian industry-led consortium for research and innovation in medical technologies. The total direct funding for the research is more than $250,000 over three years. ...
Using a cell-seeded scaffold, which we call the Biostage Bronchial Implant, or BBI, we have performed the regeneration and repair of a bronchus (the airway that connects the trachea to the lungs) that was surgically removed from a pig. ...
Neuspera Medical, a medical device company developing implantable medical device technology for patients battling chronic illness, today announced the hiring of industry veterans Melissa Farina as Chief Financial Officer and Steven Siegel, MD, as Chief Medical Officer. ...
“Since becoming THINK Surgical’s Chairman, I have gained a much deeper understanding of THINK’s overarching strategy and vision, current product offering and future technology pipeline, as well as the strength of its leadership team,” said Mr. ...
Synchron is the only company to receive FDA approval to conduct clinical trials of a permanently implanted BCI. The company’s novel BCI technology leverages the blood vessels as the natural highways to the brain. ...
The ATTUNE AFFIXIUM Knee is the first in the ATTUNE Knee portfolio to utilize this advanced 3D printing technology, which creates a three-dimensional lattice structure, generating a similar porosity to natural bone for advanced biological fixationxv and helps enhance initial implant stability.xvi “The ATTUNE AFFIXIUM Knee is a game changer for ...
This is extremely exciting for Shoulder Innovations, as we have significant demand from clinicians who want to pair a Stemless implant with our InSetTM Glenoid technology. David Blue, Chief Commercial Officer at Shoulder Innovations said, “The Stemless implant is another transformational addition to the InSet™ Shoulder System, where ...
HipXpert’s open-platform, 3D surgery planning software now supports more than 20 implant systems from leading medical technology companies. ACTIS®, CORAIL®, PINNACLE®, SUMMIT®, and TRI-LOCK® are registered trademarks of DePuy Synthes, a Johnson and Johnson ...
ByHipXpert
The open-label, multicenter, Phase IIa study met both its primary and secondary efficacy endpoints of at least 20% IOP lowering in its low dose cohort, demonstrating a potential significant benefit of the PA5108 Ocular Implant with the proprietary Prezia™ Sustained Drug Delivery Technology designed to treat patients with glaucoma by enabling a constant dose ...
Synchron is the only company to receive FDA approval to conduct clinical trials of a permanently implanted BCI. The company’s novel BCI technology leverages the blood vessels as the natural highways to the brain. ...